CSIMarket
 


Ainos Inc   (AMAR)
Other Ticker:  
 
 

AMAR's Income from Cont. Operations Growth by Quarter and Year

Ainos Inc 's Income from Cont. Operations results by quarter and year




AMAR Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.00 0.00 0.00
III Quarter September -7.82 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -7.82 0.00 0.00 0.00



AMAR Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Ainos Inc in the third quarter 2022 recorded loss from continued operations of $ -7.82 millions.

According to the results reported in the third quarter 2022, Ainos Inc achieved the best Income from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Ainos Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




AMAR Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Ainos Inc 's third quarter 2022 Income from Cont. Operations $ -7.82 millions AMAR's Income Statement
Ainos Inc 's third quarter 2021 Income from Cont. Operations $ 0.00 millions Quarterly AMAR's Income Statement
New: More AMAR's historic Income from Cont. Operations Growth >>


AMAR Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Ainos Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMAR's III. Quarter Q/Q Income from Cont. Operations Comment


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMAR's III. Quarter Q/Q Income from Cont. Operations Comment


Ainos Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Income from Cont. Operations 12 Months Ending $ -7.82 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Ainos Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -8 millions in the Sep 30 2022 period.
The situation is worsening as the cumulative loss from continued operations is becoming larger from $ 0 millions in the twelve months ending a quarter before and $ millions from the TTM period ending .

Ainos Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Ainos Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -8 millions in the Sep 30 2022 period.
The results are worsening as the cumulative loss from continued operations is inflating from $ 0 millions in the twelve months ending a quarter before and $ millions from the TTM period ending .

Ainos Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
AMAR's Income from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for AMAR's Competitors
Income from Cont. Operations Growth for Ainos Inc 's Suppliers
Income from Cont. Operations Growth for AMAR's Customers

You may also want to know
AMAR's Annual Growth Rates AMAR's Profitability Ratios AMAR's Asset Turnover Ratio AMAR's Dividend Growth
AMAR's Roe AMAR's Valuation Ratios AMAR's Financial Strength Ratios AMAR's Dividend Payout Ratio
AMAR's Roa AMAR's Inventory Turnover Ratio AMAR's Growth Rates AMAR's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022
Addus Homecare Corporation-0.29%$ -0.294 millions
Royalty Pharma Plc-0.62%$ -0.623 millions
Zoetis Inc -4.35%$ -4.348 millions
Henry Schein Inc-4.41%$ -4.410 millions
Charles River Laboratories International inc -7.18%$ -7.177 millions
Sotera Health Company-8.58%$ -8.577 millions
U S Physical Therapy Inc-9.22%$ -9.219 millions
Pediatrix Medical Group Inc -9.52%$ -9.523 millions
Ironwood Pharmaceuticals inc -9.90%$ -9.899 millions
Semler Scientific Inc -11.45%$ -11.446 millions
National Research Corporation-14.07%$ -14.073 millions
Meridian Bioscience Inc -14.30%$ -14.301 millions
Elite Pharmaceuticals Inc -15.68%$ -15.684 millions
Lemaitre Vascular Inc -16.11%$ -16.113 millions
Intuitive Surgical Inc -16.14%$ -16.142 millions
Retractable Technologies inc -17.43%$ -17.428 millions
Molecular Templates inc -18.92%$ -18.919 millions
Regeneron Pharmaceuticals Inc -19.39%$ -19.391 millions
Universal Health Services Inc -19.40%$ -19.402 millions
Zynex inc -20.21%$ -20.206 millions
Progyny Inc -21.34%$ -21.344 millions
Tenax Therapeutics Inc -23.22%$ -23.222 millions
Maravai Lifesciences Holdings Inc -24.97%$ -24.966 millions
Merck and Co Inc -28.83%$ -28.834 millions
Organon and Co -29.72%$ -29.721 millions
Gilead Sciences Inc -30.94%$ -30.936 millions
West Pharmaceutical Services Inc -31.32%$ -31.321 millions
Abbott Laboratories-31.67%$ -31.667 millions
Surgery Partners Inc -31.71%$ -31.707 millions
Biomx Inc -32.41%$ -32.410 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com